Skip to main content

Advertisement

Log in

Low-dose CT screening in an Asian population with diverse risk for lung cancer: A retrospective cohort study

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the performance of low-dose CT (LDCT) screening for lung cancer (LCA) detection in an Asian population with diverse risks for LCA.

Materials and methods

LCA screening was performed in 12,427 symptomless Asian subjects using either LDCT (5,771) or chest radiography (CXR) (6,656) in a non-trial setting. Subjects were divided into high-risk and non-high-risk groups. Data were collected on the number of patients with screening-detected LCAs and their survival in order to compare outcomes between LDCT and CXR screening with the stratification of risks considering age, sex and smoking status.

Results

In the non-high-risk group, a significant difference was observed for the detection of lung cancer (adjusted OR, 5.07; 95 % CI, 2.72–9.45) and survival (adjusted HR of LCA survival between LDCT vs. CXR group, 0.08; 95 % CI, 0.01–0.62). No difference in detection or survival of LCA was noticed in the high-risk group. LCAs in the non-high-risk group were predominantly adenocarcinomas (96 %), and more likely to be part-solid or non-solid compared with those in the high-risk group (p = 0.023).

Conclusions

In the non-high-risk group, LDCT helps detect more LCAs and offers better survival than CXR screening, due to better detection of part solid or non-solid lung adenocarcinomas.

Key Points

In an Asian non-high-risk group, LDCT helps detect more early-staged LCAs.

CT-detected lung cancers in non-high-risk subjects demonstrate better survival than CXR-detected cancers.

CT-detected lung cancers in non-high-risk subjects are predominantly part-solid or non-solid adenocarcinomas.

Mortality benefit of LDCT screening in non-high-risk subjects needs to be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

LDCT:

Low-dose CT

NLST:

National Lung Screening Trial

CXR:

Chest radiography

OR:

Odds ratio

CI:

Confidence interval

ELCAP:

Early Lung Cancer Action Project

HR:

Hazard ratio

AIS:

Adenocarcinoma in situ

MIA:

Minimally invasive adenocarcinoma

EGFR:

Epithelial growth factor receptor

References

  1. Sone S, Takashima S, Li F et al (1998) Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351:1242–1245

    Article  CAS  PubMed  Google Scholar 

  2. Henschke CI, McCauley DI, Yankelevitz DF et al (1999) Early lung cancer action project: overall design and findings from baseline screening. Lancet 354:99–105

    Article  CAS  PubMed  Google Scholar 

  3. Patz EF Jr (2006) Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project. J Natl Cancer Inst 98:724–725

    Article  PubMed  Google Scholar 

  4. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355:1763–1771

    Article  PubMed  Google Scholar 

  5. Bach PB (2011) Reduced lung-cancer mortality with CT screening. N Engl J Med 365:2036, author reply 2037–2038

    PubMed  Google Scholar 

  6. Henschke CI (2012) Re: inconsistencies in findings from the early lung cancer action project studies of lung cancer screening. J Natl Cancer Inst 104:254–255, author reply 255–256

    Article  PubMed  Google Scholar 

  7. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409

    Article  PubMed  Google Scholar 

  8. Aberle DR, Henschke CI, McLoud TC, Boiselle PM (2012) Expert opinion: barriers to CT screening for lung cancer. J Thorac Imaging 27:208

    Article  PubMed  Google Scholar 

  9. van Iersel CA, de Koning HJ, Draisma G et al (2007) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120:868–874

    Article  PubMed  Google Scholar 

  10. Pedersen JH, Ashraf H, Dirksen A et al (2009) The Danish randomized lung cancer CT screening trial: overall design and results of the prevalence round. J Thorac Oncol 4:608–614

    Article  PubMed  Google Scholar 

  11. Infante M, Lutman FR, Cavuto S et al (2008) Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 59:355–363

    Article  PubMed  Google Scholar 

  12. Lopes Pegna A, Picozzi G, Mascalchi M et al (2009) Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64:34–40

    Article  PubMed  Google Scholar 

  13. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK (2011) UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 66:308–313

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Blanchon T, Brechot JM, Grenier PA et al (2007) Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 58:50–58

    Article  PubMed  Google Scholar 

  15. Progetto MILD Multicentric Italian Lung Detection. Available via http://www.capolmone.org/mild.htm. Accessed 26 Jun 2007

  16. Travis WD, Brambilla E, Muller-Hermelink HK et al (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon

    Google Scholar 

  17. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474

    Article  PubMed  Google Scholar 

  18. Travis WD, Brambilla E, Noguchi M et al (2011) International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–285

    Article  PubMed  Google Scholar 

  19. Villa C, Cagle PT, Johnson M et al (2014) Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society. Arch Pathol Lab Med. doi:10.5858/arpa.2013-0376-OA

    Google Scholar 

  20. Sun PL, Seol H, Lee HJ et al (2012) High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features. J Thorac Oncol 7:323–330

    Article  CAS  PubMed  Google Scholar 

  21. Aoki T, Hanamiya M, Uramoto H, Hisaoka M, Yamashita Y, Korogi Y (2012) Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers. Radiology 264:590–596

    Article  PubMed  Google Scholar 

  22. Tsubamoto M, Kuriyama K, Kido S et al (2002) Detection of lung cancer on chest radiographs: analysis on the basis of size and extent of ground-glass opacity at thin-section CT. Radiology 224:139–144

    Article  PubMed  Google Scholar 

  23. Lim HJ, Ahn S, Lee KS et al (2013) Persistent pure ground-glass opacity lung nodules >/= 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 144:1291–1299

    Article  PubMed  Google Scholar 

  24. Chang B, Hwang JH, Choi YH et al (2013) Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 143:172–178

    Article  PubMed  Google Scholar 

  25. Kakinuma R, Ohmatsu H, Kaneko M et al (2004) Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 28:17–23

    Article  PubMed  Google Scholar 

  26. Min JH, Lee HY, Lee KS et al (2010) Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer 69:123–126

    Article  PubMed  Google Scholar 

  27. Devaraj A (2014) Missed cancers in lung cancer screening – more than meets the eye. Eur Radiol

  28. Scholten ET, Horeweg N, de Koning HJ et al (2014) Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening. Eur Radiol

Download references

Acknowledgments

The scientific guarantor of this publication is Kyung Soo Lee. This study received funding from the Korean Foundation for Cancer Research, KFCR-CB-201103. Myung-Hee Shin has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was waived by the Institutional Review Board. This is a retrospective case-control study performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyung Soo Lee.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Table S1

(DOCX 41 kb)

Supplemental Table S2

(DOCX 37 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yi, C.A., Lee, K.S., Shin, MH. et al. Low-dose CT screening in an Asian population with diverse risk for lung cancer: A retrospective cohort study. Eur Radiol 25, 2335–2345 (2015). https://doi.org/10.1007/s00330-015-3620-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3620-8

Keywords

Navigation